Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 503601 - 503620 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.25MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.25MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.35MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.35MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.35MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.35MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.5MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.5MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.75MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.75MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XK04) talazoparib | TALZENNA 1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01XL03) axicabtagene ciloleucel | YESCARTA | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular;Lymphoma, Large B-Cell, Diffuse | GileadSciences,Inc. |
| USA | (L01XL03) axicabtagene ciloleucel | YESCARTA | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular;Lymphoma, Large B-Cell, Diffuse | GileadSciences,Inc. |
| USA | (L01XL06) brexucabtagene autoleucel | TECARTUS INFUSION BAG | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell | GileadSciences,Inc. |
| USA | (L01XL06) brexucabtagene autoleucel | TECARTUS INFUSION BAG | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell | GileadSciences,Inc. |
| USA | (L01XL06) brexucabtagene autoleucel | TECARTUS INFUSION BAG | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell | GileadSciences,Inc. |
Pages
